Legal & General Group
COGT icon

Legal & General Group’s Cogent Biosciences COGT Stock Holding History

Legal & General Group’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.82M Buy
98,820
+17,577
+22% +$615K ﹤0.01% 1704
2026
Q1 		$3.13M Sell
81,243
-17,232
-17% -$636K ﹤0.01% 1728
2025
Q4 		$3.5M Sell
98,475
-339
-0.3% -$9.53K ﹤0.01% 1756
2025
Q3 		$1.42M Buy
98,814
+18,769
+23% +$222K ﹤0.01% 2121
2025
Q2 		$575K Buy
80,045
+10,878
+16% +$60.3K ﹤0.01% 2404
2025
Q1 		$414K Sell
69,167
-374
-0.5% -$2.93K ﹤0.01% 2453
2024
Q4 		$542K Buy
69,541
+1,911
+3% +$19K ﹤0.01% 2432
2024
Q3 		$730K Buy
67,630
+330
+0.5% +$3.21K ﹤0.01% 2343
2024
Q2 		$567K Buy
67,300
+13,182
+24% +$100K ﹤0.01% 2381
2024
Q1 		$364K Sell
54,118
-700
-1% -$4.33K ﹤0.01% 2546
2023
Q4 		$322K Buy
54,818
+449
+0.8% +$3.44K ﹤0.01% 2606
2023
Q3 		$530K Buy
54,369
+439
+0.8% +$5.21K ﹤0.01% 2412
2023
Q2 		$639K Buy
53,930
+38,383
+247% +$440K ﹤0.01% 2376
2023
Q1 		$168K Buy
15,547
+1,128
+8% +$14.4K ﹤0.01% 2646
2022
Q4 		$167K Buy
14,419
+8,449
+142% +$105K ﹤0.01% 2682
2022
Q3 		$89K Buy
5,970
+2,203
+58% +$30.2K ﹤0.01% 2856
2022
Q2 		$34K Buy
3,767
+529
+16% +$3.61K ﹤0.01% 3081
2022
Q1 		$24K Hold
3,238
– – ﹤0.01% 3183
2021
Q4 		$28K Hold
3,238
– – ﹤0.01% 3170
2021
Q3 		$27K Hold
3,238
– – ﹤0.01% 3159
2021
Q2 		$26K Buy
+3,238
New +$27.3K ﹤0.01% 3189
2019
Q3 		– Sell
-741
Closed -$8K – 3363
2019
Q2 		$8K Hold
741
– – ﹤0.01% 3390
2019
Q1 		$13K Hold
741
– – ﹤0.01% 3202
2018
Q4 		$13K Buy
741
+554
+296% +$16.4K ﹤0.01% 3213
2018
Q3 		$8K Hold
187
– – ﹤0.01% 3340
2018
Q2 		$11K Buy
+187
New +$8.99K ﹤0.01% 3289

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Legal & General Group's COGT Position: Q2 2026 in Review

Legal & General Group increased its Cogent Biosciences (COGT) stake by 22% in Q2 2026, buying an estimated $615K and bringing the position to 98,820 shares worth $3.82M. The position accounts for ﹤0.01% of the portfolio, ranked #1704.

Legal & General Group first reported a position in COGT in Q2 2018 and has held it in 26 quarters since. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Legal & General Group held 98,820 shares of Cogent Biosciences worth $3.82M as of Q2 2026.
  • Legal & General Group bought 17,577 Cogent Biosciences shares in Q2 2026, an estimated $615K.
  • Cogent Biosciences made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #1704 holding.
  • Legal & General Group first reported a position in Cogent Biosciences in Q2 2018 and has held it in 26 quarters since.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.